NYSE · OSG

Octave Specialty Group, Inc.

$5.82 +$0.23 (+4.03%) 1D Market open

Key Metrics

$251.63M
Market cap
P/E · TTM
$292.64M
Revenue · TTM
−$221.21M
Net income
EPS · TTM $-4.68
Dividend yield
Free cash flow
Beta · 1Y -0.15
EBITDA · TTM −$44.26M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved +43.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Apr 10
    From its Feb 5 high, the share price fell 37%.

    Peak close $6.21 on Feb 5; trough close $3.94 on Apr 10. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -37%
  • Apr 8
    The stock moved -11.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 8

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$251.63M
Enterprise value$139.30M
Shares outstanding45.0M
52-wk range$3.88 – $9.55
Avg volume · 20D627.1K
Net cash $112.33M
Book value / share$15.06
IndustrySurety Insurance
ExchangeNYSE
About Octave Specialty Group, Inc.
IPO dateAug 25, 1989
Employees275

Octave Specialty Group Inc is a world-wide specialty insurance firm that provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.86
P/FCF
EV/EBITDA
EV/Sales0.48
Graham №

Profitability

Gross
Operating -30.5%
Net -75.6%
FCF
ROE / ROIC -28.2% · -15.8%

Financial Health

Current ratio
Quick ratio
Debt / equity0.16
Debt / EBITDA -2.64
Net cash $112.33M
Working capital

Cash Flow · TTM

Operating CF −$49.75M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

0.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings